James J. Hoogasian

591 total citations
8 papers, 486 citations indexed

About

James J. Hoogasian is a scholar working on Immunology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, James J. Hoogasian has authored 8 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Surgery and 2 papers in Pathology and Forensic Medicine. Recurrent topics in James J. Hoogasian's work include Cholesterol and Lipid Metabolism (2 papers), Reproductive System and Pregnancy (2 papers) and Immune Response and Inflammation (2 papers). James J. Hoogasian is often cited by papers focused on Cholesterol and Lipid Metabolism (2 papers), Reproductive System and Pregnancy (2 papers) and Immune Response and Inflammation (2 papers). James J. Hoogasian collaborates with scholars based in United States and South Korea. James J. Hoogasian's co-authors include Peter H. Levine, Marc Fisher, Mark H. Johnson, A Natale, Bonnie H. Weiner, J. Jarmolych, Henri Cuénoud, Assaad S. Daoud, Brian F. G. Johnson and Ira S. Ockene and has published in prestigious journals such as New England Journal of Medicine, Neurology and American Journal of Hematology.

In The Last Decade

James J. Hoogasian

8 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James J. Hoogasian United States 6 293 194 131 67 62 8 486
Tatsuto Notsu Japan 16 131 0.4× 87 0.4× 73 0.6× 90 1.3× 105 1.7× 19 628
Masayuki Ueeda Japan 12 131 0.4× 88 0.5× 68 0.5× 150 2.2× 41 0.7× 19 378
Robin Doyle United States 6 155 0.5× 75 0.4× 53 0.4× 21 0.3× 128 2.1× 8 404
L. F. Larsen Denmark 9 90 0.3× 70 0.4× 33 0.3× 29 0.4× 69 1.1× 13 425
S. Narasimha Rao United Kingdom 9 92 0.3× 222 1.1× 49 0.4× 135 2.0× 80 1.3× 13 485
Yousheng Li China 10 129 0.4× 59 0.3× 86 0.7× 23 0.3× 57 0.9× 19 350
Kiyoko Matsui Japan 4 74 0.3× 73 0.4× 16 0.1× 92 1.4× 78 1.3× 5 425
M. Böhme Germany 6 42 0.1× 58 0.3× 56 0.4× 150 2.2× 196 3.2× 15 364
Tayze T. Antunes Canada 15 126 0.4× 81 0.4× 23 0.2× 74 1.1× 118 1.9× 19 596
Noboru Yoshimine Japan 10 39 0.1× 95 0.5× 16 0.1× 47 0.7× 57 0.9× 38 385

Countries citing papers authored by James J. Hoogasian

Since Specialization
Citations

This map shows the geographic impact of James J. Hoogasian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James J. Hoogasian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James J. Hoogasian more than expected).

Fields of papers citing papers by James J. Hoogasian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James J. Hoogasian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James J. Hoogasian. The network helps show where James J. Hoogasian may publish in the future.

Co-authorship network of co-authors of James J. Hoogasian

This figure shows the co-authorship network connecting the top 25 collaborators of James J. Hoogasian. A scholar is included among the top collaborators of James J. Hoogasian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James J. Hoogasian. James J. Hoogasian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Fackelman, Gustave E., et al.. (1993). Studies on propentofylline for the treatment of navicular disease. Journal of Equine Veterinary Science. 13(2). 106–113+(114). 1 indexed citations
2.
Fisher, Marc, et al.. (1991). A 21‐aminosteroid inhibits stimulated monocyte hydrogen peroxide and chemiluminescence measurements from MS patients and controls. Neurology. 41(2_part_1). 297–297. 6 indexed citations
3.
Fisher, Marc, Peter H. Levine, Bonnie H. Weiner, et al.. (1988). Monocyte and polymorphonuclear leukocyte toxic oxygen metabolite production in multiple sclerosis. Inflammation. 12(2). 123–131. 37 indexed citations
4.
Weiner, Bonnie H., Ira S. Ockene, Peter H. Levine, et al.. (1986). Inhibition of Atherosclerosis by Cod-Liver Oil in a Hyperlipidemic Swine Model. New England Journal of Medicine. 315(14). 841–846. 290 indexed citations
5.
Fisher, Marc, Katherine S. Upchurch, Peter H. Levine, et al.. (1986). Effects of dietary fish oil supplementation on polymorphonuclear leukocyte inflammatory potential. Inflammation. 10(4). 387–392. 93 indexed citations
6.
Fisher, Mark, et al.. (1982). Marker Proteins of Platelet Activation in Patients With Cerebrovascular Disease. Archives of Neurology. 39(11). 692–695. 50 indexed citations
7.
Levine, Peter H., et al.. (1981). Human platelet factor 4: Preparation from outdated platelet concentrates and application in cerebral vascular disease. American Journal of Hematology. 10(4). 375–385. 8 indexed citations
8.
Lau, I.F., et al.. (1980). Effects of prostaglandin-F2α and an antiprogestational steroid, RMI 12,936, on rat pregnancy. Prostaglandins and Medicine. 4(2). 121–132. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026